Volume: 57s3 - Number: - year 1986
INAUGURATION
INAUGURATION - Opening addresses
Horst Franak
PDF
INAUGURATION - Opening addresses - part II
Hans-Achim Muller
PDF
INAUGURATION - Opening addresses - part III
Klaus Zeitler
PDF
Tribute to Professor Dr Enno Freerksen and Dr Harold Wheate
Hubert Count Ballestrem
PDF
Reply from Professor Dr Enno Freerksen
PDF
Keynote address
Klaus Fleischer
PDF
ABSTRACTS
PDF
SESSION I. CLINICAL ASPECTS. CHAIRMAN: D. L. LEIKER
The Malta experience. Isoprodian-rifampicin com bination treatment for leprosy
G. De Pasquale
PDF
On the epidemiology of leprosy in Malta
D. L. Leiker
PDF
First assessment of the Malta Leprosy Eradication Project
D. L. Leiker
PDF
A report on two follow-up investigations of the Malta-Project
W. H. Jopling
PDF
Report of the Joint Leprosy - Tuberculosis Project in Paraguay
A. E. Alvarenga
PDF
Comparison of DDS with two combined chemotherapy regimens for multibacillary leprosy. Results after 3 years of treatment. A prospective randomized multicentre study
M. Dietrich and R. Wabitsch
PDF
The impact of MDT implementation in the Tanzania National TB-Leprosy Programme
H. J. Chum
PDF
Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases
J. Mehta, I. S. Gandhi, S. B. Sane and M. N. Wamburkar
PDF
Experience with multidrug therapy in Sierra Leone: clinical, operational and managerial analysis
M. Rangaraj and J. Rangaraj
PDF
Clinical problems in the initiation and assessment of multidrug therapy
M. F. R. Waters, D. S. Ridley and Marian J. Ridley
PDF
Preliminary evaluation of the effect of WHO-MDT on disabilities in leprosy patients in Malawi (Central Africa)
G. Boerrigter and J. M. Ponnighaus
PDF
The use of MDT in the three Western Regions of Nepal
P. G. Kalthoff
PDF
Operational aspects of the implementation of multidrug therapy at ALERT, Ethiopia
Marijke Becx-Bleumink
PDF
Combined chemotherapy of multibacillary leprosy of 6 months' duration
N. Onsun, T. Saylan and S. R. Pattyn
PDF
The future of leprosy in the Dominican Republic: experience with multidrug therapy
Denis Martinez Cruz
PDF
SESSION II. TEST MODELS FOR THE EFFECTIVE CONTROL OF CHEMOTHERAPY FREE COMMUNICATION. CHAIRMAN: A. M. DHOPLE
The use of rodent models in assessing antimicrobial activity against Mycobacterium leprae
R. H. Gelber
PDF
Limited in vitro multiplication of Mycobacterium leprae: application to screening potential antileprosy compounds
A. M. Dhople and Kara J. Green
PDF
Single bacterial cell mass analysis: a rapid test method in leprosy therapy control
U. Seydel and B. Linder
PDF
Metabolism in Mycobacterium leprae: possible targets for drug action
P. R. Wheeler
PDF
Host-pathogen interaction- new in vitro drug test systems against Mycohacterium lepraepossibilities and limitations
P. R. Mahadevan, R. Jagannathan, A. Bhagaria, S. Vejare and S. Agrawal
PDF
Isolation of environment-derived Mycobacterium leprae from soil in Bombay
J. Kazda, R. Ganapati, C. Revankar, T. M. Buchanan, D. B. Young and L. M. Irgens
PDF
Investigations into the cultivation of Mycobacterium leprae. A multifactorial approach
L. Kato
PDF
SESSION III. DEVELOPMENTS AND FUTURE ASPECTS.. CHAIRMAN: ENNO FREERKSEN
Recent developments in the field of multidrug therapy and future research in chemotherapy of leprosy
J. H. Grosset
PDF
Strategies in the development of new drugs and drug combinations against leprosy, demonstrated on the example of folate and gyrase inhibitors
J. K. Seydel, M. Rosenfeld, M. Sathish, M. Weise, K. J, Schaper, G. Hachtel, R. Haller, M. Kansy and A. Dhople
PDF
Development of inhibitors of mycobacterial ribonucleotide Reductase
K. J. Schaper, J. K. Seydel, M. Rosenfeld and J. Kazda
PDF
Efficacy of different regimens in multibacillary leprosy
S. R. Pattyn
PDF
Preliminary results of treatment of leprosy patients in The Netherlands with daily rifampicin, dapsone and clofazimine
D. L. Leiker
PDF
Final bulletin
D. L. Leiker, A. M. Dhople and Enno Freerksen
PDF
ADDENDUM
Multidrug therapy cost: a hypothetical analysis
C. R, Revankar
PDF
Discussions
PDF
List of participants
PDF
